Cellestia Biotech Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 19
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 8

Cellestia Biotech General Information

Description

Developer of drugs and therapeutics intended to focus on the field of precision oncology. The company develops targeted therapies built on a unique mode of action of targeting protein-protein interactions with small molecules to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus, thereby enabling healthcare companies to pursue an integrated approach by combining drug and personalized medicine development for patient selection.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Primary Office
  • Technology Park Basel
  • Hochbergerstrasse 60C
  • 4057 Basel
  • Switzerland

Cellestia Biotech Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellestia Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 17-Aug-2021 000.00 Completed Clinical Trials - Phase 2
6. Later Stage VC (Series B) 17-Dec-2019 0000 000.00 000.00 Completed Clinical Trials - Phase 1
5. Early Stage VC (Series A) 20-Dec-2018 000.00 000.00 000.00 Completed Clinical Trials - Phase 1
4. Seed Round 10-Apr-2018 00.000 00.000 000.00 Completed Clinical Trials - Phase 1
3. Grant 00.000 000.00 Completed Startup
2. Debt - General 26-Jun-2015 $32.1K $32.1K Completed Startup
1. Seed Round 01-May-2014 Completed Startup
To view Cellestia Biotech’s complete valuation and funding history, request access »

Cellestia Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000,000 000.00 000.00 00 000.00 00.000
Ordinary 0,000,000 000.00 000.00 00 000.00 00.000
Ordinary 000,000 00.00 00.00 00 00.00 000
Ordinary 346,341 $6.65 $6.65 1x $6.65 7.09%
Ordinary 83,473 $6.04 $6.04 1x $6.04 1.71%
To view Cellestia Biotech’s complete cap table history, request access »

Cellestia Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drugs and therapeutics intended to focus on the field of precision oncology. The company develops targeted
Drug Discovery
Basel, Switzerland
19 As of 2021
000.00
0000000000 0 000.00

0000000

quip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000000000000
Abingdon, United Kingdom
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

00000 00

itation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehende
0000000000000
Wilmington, DE
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cellestia Biotech Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PsiOxus Therapeutics Venture Capital-Backed Abingdon, United Kingdom 00 000.00 00000000000 000.00
00000 000000000000 Formerly VC-backed Wilmington, DE 00 00000 000000000 00000
000 000000000000 Formerly VC-backed Epalinges, Switzerland 000 00.000 00000000 00.000
000000 Venture Capital-Backed Cambridge, United Kingdom 00 00000 00000000000 00000
00000000000 000000 Formerly VC-backed Stamford, CT 000 00000 00000000 00000
You’re viewing 5 of 5 competitors. Get the full list »

Cellestia Biotech Patents

Cellestia Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210323921-A1 Process for making amino diaryl ethers and amino diaryl ethers hydrochloride salts Pending 21-Jun-2018 0000000000

Cellestia Biotech Executive Team (8)

Name Title Board Seat Contact Info
Michael Bauer Ph.D Co-Founder, Chief Executive Officer & Board Member
Gaudenz von Capeller Chief Financial Officer
Rajwinder Lehal Ph.D Co-Founder, Chief Scientific Officer & Board Member
Freddy Radtke Ph.D Co-Founder & Chairman
Florian Vogl Ph.D Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Cellestia Biotech Board Members (7)

Name Representing Role Since
Freddy Radtke Ph.D Cellestia Biotech Co-Founder & Chairman 000 0000
Guido Guidi MD Self Chairman 000 0000
Melissa Epstein JD Cellestia Biotech Board Member 000 0000
Michael Bauer Ph.D Cellestia Biotech Co-Founder, Chief Executive Officer & Board Member 000 0000
Rajwinder Lehal Ph.D Cellestia Biotech Co-Founder, Chief Scientific Officer & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Cellestia Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellestia Biotech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SNGLR Capital Venture Capital Minority 000 0000 000000 0
Partners Investment Venture Capital Minority 000 0000 000000 0
SOTIO PE-Backed Company Minority 000 0000 000000 0
Emerging Technology Partners Venture Capital Minority 000 0000 000000 0
FC Capital (China) Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »